| | Dental Health | Gum Disease
Batten Disease (NCL) Detection: Genetic, Enzyme, Imaging & Biopsy Methods
Neuronal Ceroid Lipofuscinoses (NCLs, Batten disease) are 14+ autosomal recessive lysosomal storage disorders (CLN1–14). Diagnosis requires a tiered approach.
Diagnostic Algorithm
- Clinical suspicion: Regression, seizures, vision loss, ataxia, dementia (childhood onset).
- Genetic testing (first-line):
- Targeted NCL panel (CLN1–14) or exome/genome sequencing.
- Identifies pathogenic variants; confirms diagnosis, enables carrier testing.
- Enzyme assay (if gene unknown/VUS):
- PPT1 (CLN1), TPP1 (CLN2), CLN3, CLN5, CLN8 – measured in leukocytes/fibroblasts.
- Deficient activity confirms specific type.
- MRI brain:
- Cerebral/cerebellar atrophy.
- Thalamus hyperintensity (CLN3).
- Posterior white matter changes.
- EEG: Background slowing, epileptiform discharges, photoparoxysmal response.
- Ophthalmology: ERG (electroretinogram) – early rod/cone loss; macular bull's-eye.
- Biopsy (rare now): Skin/rectal/conjunctival – fingerprint/curvilinear/granular osmiophilic deposits (EM).
Multidisciplinary Care
- Neurology, genetics, ophthalmology, metabolism, palliative care.
- Clinical trials: enzyme replacement (CLN2 cerliponase alfa), gene therapy, small molecules.
Early genetic diagnosis enables family counseling and trial access.
Gum Disease - Related Articles
- Understanding Gum Disease: Symptoms, Causes & Treatment
- Strep Throat After Tonsillectomy: Still Possible—Here's Why
- Effective Ways to Repair Receding Gums Between Teeth
- Refractory Periodontitis: Understanding Treatment Challenges
- Deep Cleaning: Understanding Procedures for Gum Health
- Toilet Seat Germs: Real Transmission Risk & Simple Prevention
- Receding Gums: Why They Don't Grow Back and Treatment Options
